Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$7,602,347
+$1,557,564 QoQ
Shares Held
20,994
+22.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#649
of 3,140 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $242,744,034 across 9 Drug Manufacturers - General names. AMGN ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
452,664 | $58,167,324 | |
| 2 | JNJ |
Johnson & Johnson
|
211,287 | $53,660,559 | |
| 3 | ABBV |
AbbVie Inc.
|
146,723 | $36,921,375 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
558,264 | $32,167,171 | |
| 5 | PFE |
Pfizer Inc
|
1,137,828 | $27,398,898 | |
| 6 | LLY |
ELI LILLY & Co
|
14,911 | $17,884,702 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
67,881 | $8,576,085 | |
| 8 | AMGN |
Amgen Inc
This page
|
20,994 | $7,602,347 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,602,347 | 20,994 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $6,044,783 | 17,180 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $6,120,041 | 18,698 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $5,293,789 | 18,759 | Shares | Other | 2025-11-05 | |
| 2025-06-30 | $3,212,310 | 11,505 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $3,614,291 | 11,601 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $2,723,426 | 10,449 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,837,842 | 11,911 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,811,249 | 25,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,620,959 | 23,287 | Shares | Other | 2024-05-14 | |
| 2023-12-31 | $6,998,021 | 24,297 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $6,544,843 | 24,352 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,975,424 | 31,418 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,796,679 | 32,251 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $9,281,960 | 35,341 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,799,106 | 136,642 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $40,789,001 | 167,649 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $25,922,136 | 107,196 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,795,068 | 110,215 | Shares | Defined | 2022-02-09 | |
| 2020-12-31 | $245,094 | 1,066 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $276,271 | 1,087 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $229,491 | 973 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $219,151 | 1,081 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||